Shellaina JV Gordon 38th Lorne Cancer Conference 2026

Abstracts this author is presenting:

• Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia — Session 1: Stem Cells and Leukaemia